Clinical trial
StrataGraft® Skin Tissue as an Alternative to Autografting Deep…
NCT01437852 · Stratatech, a Mallinckrodt Company, Industry · Completed
Key facts
| NCT number | NCT01437852 |
|---|---|
| Title | StrataGraft® Skin Tissue as an Alternative to Autografting Deep Partial-Thickness Burns |
| Official title | An Open-Label, Controlled, Randomized, Multicenter, Dose Escalation Study Evaluating the Safety and Efficacy of StrataGraft® Skin Tissue in Promoting the Healing of the Deep Partial-Thickness Component of Complex Skin Defects as an Alternative to Autografting |
| Lead sponsor | Stratatech, a Mallinckrodt Company, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Skin Wound, Burns, Trauma-related Wound |
| Intervention type | Biological |
| Interventions | StrataGraft Skin Tissue |
| Enrollment | 30 |
| Start date | Sep 1, 2011 |
| Primary completion | Jan 1, 2014 |
| Completion | Oct 1, 2014 |
| First posted | Sep 21, 2011 |
| Last update posted | Oct 16, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: